Distinguished Professor Dietmar W. Hutmacher is the Director of the Centre in Regenerative Medicine and Director of the Australian Research Council Centre in Additive Biomanufacturing at the Queensland University of Technology (QUT). He holds a MBA from the Royal Henley Management College and a PhD from the National University of Singapore. He has a distinctive research record, educational and scholarly career combined with a former leadership position and industry experience.
He has world renown expertise in biomaterials & biomedical engineering and tissue engineering & regenerative medicine (TE&RM). He is not only among the pioneers in the field of 3D printing in Medicine yet also developed an outstanding track record in two new cutting-edge research areas, namely ‘3D in vitro cancer models’ and ‘humanized animal models’ via the translation of tissue engineering technologies into cancer research. His international standing and impact on the field are illustrated by his publication record, with more than 300 journal articles, 24 book chapters, 14 edited books; and outstanding citation record: more than 25,000 citations and an h-index of 76.
In 2012 he was, 1) elected to join the highly esteemed International College of Fellows Biomaterials Science and Engineering; 2) elected to become one of the 23 founding members of the International Fellows of Tissue Engineering and Regenerative Medicine Society (TERMIS); 3) presented the Research Excellence Award from the Australasian Society for Biomaterials and Tissue Engineering. In 2013, he received the highly prestigious Hans Fischer Senior Fellowship from the Technical University in Munich. In 2017 he was 1) given the most prestigious award of the European Society for Biomaterials; 2) QUT awarded him the title Distinguished Professor. In 2018 he received the Humboldt Research Award.
He is an Adjunct Professor at the Georgia Institute of Technology for more than one decade. Over the past 20 years in academia, he has been a lead CI, Co-CI or collaborator on research and infrastructure grants totaling more than AU$50M. Over the last 10 years at QUT, he has been an investigator on external grants totaling more than AU$25M. He serves on the editorial boards of leading journals in his fields. He maintains strong relationships within the global biomaterials, TE&RM and cancer research community. Over the last 20 years, he has been invited to give more than 50 plenary & keynote lectures at national and international conferences, has served on 30 organizing committees for international conferences, chaired more than 80 sessions. A number of medical device and tissue engineering projects have been patented and commercialized under his mandate; he is a founder of 5 spin off companies. Over the last two decades Prof Hutmacher research has featured many times in mainstream media formats including newspapers, radio and television.